A network-driven computational framework for identifying FDA-approved drug repurposing across heterogeneous brain cancers
{{output}}
Background: Brain cancers are notorious for their heterogeneity, which complicates therapeutic decisions because of recurrently dysregulated signaling pathways. Cancer system characterizations have allowed the identification of s... ...
